search
Front

Pitango HealthTech II announces first closing of $175m fund

Pitango Healthcare II team credit: Yoram Reshef
Pitango Healthcare II team credit: Yoram Reshef
6 Sep, 2023 15:15
שלח תגובה במיילGlobes correspondent

The fund will invest in data science, AI, medical devices and novel biology startups.

Pitango HealthTech, Pitango VC's dedicated healthcare fund, today announced the first closing of its second healthcare fund, Pitango HealthTech II, a $175M fund, which will invest in data science, AI, medical devices and novel biology startups.

Pitango HealthTech II will invest in healthcare innovation, including the decentralization of healthcare, personalized medicine, medical devices and diagnostics, as well as artificial intelligence, software and data infrastructure.

Pitango HealthTech managing partner Ittai Harel said, "Despite the global and local macroeconomic challenges, the healthcare sector continues to show resilience and growth. Recent events such as the pandemic, decentralization of healthcare, and value-based care, have resulted in unprecedented openness towards the adoption of new technologies. We’re launching this new fund to continue to back entrepreneurs and invest in companies that are revolutionizing the healthcare industry. Pitango believes that the most promising healthcare innovations occur at the convergence of life science and medical technologies with data science and AI, coupled with innovative services. This revolution is at its early onset, and is yet to accelerate."

Pitango HealthTech invests in companies from seed to commercial stage. The fund’s investment strategy is focused on all segments of healthcare and life sciences. Previous investments include value-driving companies such as Protai, Laguna Health, Vertos, Visby, Clew and Magenta. The first investments of the newest fund are QuantHealth.ai, an AI company focused on clinical trial simulations to accelerate and de-risk drug development, and Nevia Bio, a FemTech company developing an AI-based biomarker platform for early detection of women’s health diseases.

Pitango HealthTech managing partner Hila Karah said, "The current environment offers great investment opportunities for health tech investors. Our team has decades of experience working with global healthcare providers, payers, medical device and pharma companies. We garner this expertise to support our portfolio companies from inception to scale. We’re seeing an incredible generation of companies being formed right now and are looking forward to working with the best of them."

Pitango HealthTech is committed to promoting diversity within the healthcare technology space, upholding ESG standards and ensuring women founders in the domain receive the same access to investment opportunities.

Pitango HealthTech is part of the Pitango investment platform, operating alongside Pitango First and Pitango Growth Funds. Since its inception in 1993, Pitango has invested in over 250 companies and seen more than 85 become publicly traded companies, or acquired by strategic players.

Pitango cofounder and managing partner Rami Kalish said, "Pitango has been a key player in the healthcare ecosystem in Israel since its inception. Over the last three decades we've had the opportunity to invest in over 50 healthcare companies and see 15 of them exit successfully and many others on a strong growth trajectory. It’s a track record we’re proud of and that gives us the confidence to double down with a second dedicated healthcare fund."

Published by Globes, Israel business news - en.globes.co.il - on September 6, 2023.

© Copyright of Globes Publisher Itonut (1983) Ltd., 2023.

Pitango Healthcare II team credit: Yoram Reshef
Pitango Healthcare II team credit: Yoram Reshef
Work on the Green Line credit: Bar Lavi Egged wins tender to operate TA light rail Purple, Green Lines

NTA awarded the tender to Egged, which already operates the Red Line, despite government ministry opposition to one operator for the entire network.

Amnon Shashua and Aviram Ziv credit: Eyal Izhar OrCam stymied by investor dispute with Shashua

Demands by institutional investors are blocking the visual and hearing impairment device developer's recovery plan.

Bria CEO Yair Adato credit: Kseniia Poliak Israeli visual generative AI co Bria raises $40m

Bria’s Visual Generative AI platform empowers businesses to create predictable, controllable, and on-brand content that aligns with their visual language.

Tel Aviv credit: Shutterstock Supply of unsold new homes hits record

Israel's real estate market is sliding into recession with 78,000 unsold new apartments in January, the Central Bureau of Statistics reports.

El Al aircraft credit: Yoav Yaari El Al pilots receive nearly NIS 250,000 bonus each

Thanks to the agreements signed with the unions in 2018, El Al's employees as well as senior management share in last year's success.

Bavli Park penthouse credit: Eyal Tagar Tel Aviv Park Bavli penthouse sells for NIS 43m

A 44th floor penthouse in one of the two towers in businessman Yitzhak Tshuva's Park Bavli project has been bought by an Israeli businessperson.

Dina Ben Tal Ganancia credit: Guy Kushi & Yariv Fein El Al almost quintuples profit

The airline posted a net profit of $545 million for 2024, 4.7 times the profit in 2023, and an all-time high.

First International Bank of Israel CEO Eli Cohen credit: Eyal Toueg First Int'l posts top return on equity

First International Bank of Israel's return on equity in 2024 was 19%, the highest among Israel's banks.

Matrix IT CEO Moti Gutman credit: Idan Gross Matrix CEO Gutman among highest paid execs at TASE cos

Moti Gutman's total compensation cost in 2024 was NIS 23.7 million. Matrix posted 14.4% growth in operating profit.

Matrix Hq in Kfar Saba credit: Matrix Matrix to buy Magic in major Israeli IT merger

Magic will become wholly owned by Matrix in a triangular reverse merger. The combined company is expected to have a market cap of NIS 7.7 billion.

Bank Hapoalim branch credit: Aviv Gottlieb Bank Hapoalim raising NIS 3b

The bank is offering two series of CoCo bonds, one of which is for 25 years, and 12-month commercial paper.

Ronit Harel Ben Zeev credit: Osnat Rom S&P Maalot Israel CEO: Capital market needs more women

Ronit Harel Ben Zeev talks to "Globes" about she came to work at the Tel Aviv Stock Exchange, the Israeli economy and S&P Maalot.

Finance Minister Bezalel Smotrich credit: GPO Yossi Zamir Israel's fiscal deficit narrows for fifth straight month

Record tax revenues and lower government spending due to the ceasefire and restrictions until the 2025 budget is passed have improved the fiscal deficit.

Ben Gurion Airport credit: Shutterstock Ukraine war refugees skew Israel's migration figures

Many who left Israel in 2023 were recent arrivals from Ukraine and Russia - but even without them there was a large exit of the young and educated.

Bank of Israel credit: Shutterstock Israel's forex reserves jumped in February

Israel’s foreign exchange reserves at the end of February 2025 rose to $220.253 billion, an increase of $4.185 billion from their level at the end of January, the Bank of Israel reports.

Haifa Port credit: Shlomi Yosef How Trump tariffs could benefit Israel

Israel's free trade agreement with the US makes it an attractive investment destination for companies seeking to preserve access to the US market.

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018